Health
Maciej Walczak, associate professor of chemistry, won a $2 million NIH grant to investigate how certain sugars modify a brain protein associated with neurodegeneration.
New research shows that cancer cells can adapt in as little as one to two hours to new drugs called CDK2 inhibitors. The good news: Adding a second, widely available drug disables this workaround, squelching tumor growth.
An ancient, virus-like protein best known for its essential role in placental development may, when over-expressed, fuel ALS—aka Lou Gehrig's disease—and other neurodegenerative diseases, according to new research. The discovery opens the door to a new class of potential treatments.
A revolutionary technique for editing genomes, called CRISPR-Cas9, has already helped cure sickle cell disease in dozens of people. But it also raises ethical concerns, which a panel of preeminent scientists grappled with at an event on the campus.
A study led by a researcher finds that flavored tobacco products reduce the likelihood of cessation later, but researchers say more investigation is needed.
A new study led by Angela Bryan, a professor and cancer survivor, is among the first to assess how cannabis bought over the counter at dispensaries—rather than government-supplied or synthetic varieties—impacts cancer symptoms or chemotherapy side effects.
The study of 46 million births across nearly three decades is among the first to provide population-level statistical evidence of “obstetric racism,” a term coined recently to describe a concerning pattern of maltreatment of non-white pregnant women, including a disregard for their birthing wishes.
Imagine carrying a UV device in your backpack and pulling it out to disinfect your bus seat or restaurant table. A new study shows that using a technology called Far UV-C kills almost 100% of pathogens within a few seconds, without risk to human bystanders.
By inhibiting a protein that helps cancer cells repair themselves, scientists hope to develop new drugs that treat resistant tumors with fewer side effects.
A new “digital nose” created with Nobel Prize-winning CU technology can provide COVID-19 test results in less than one hour with excellent accuracy. It could ultimately be used for on-the-go virus testing, diagnosis of cancer and lung diseases and more.